Amyloid-beta drug
Evidence from:
primary |
all sources
Related entities (5)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| Amyloid-beta | biomarker_for | Alzheimer's disease | — | 2 |
| Amyloid-beta | interacts_with | Amyloid beta | — | 1 |
| Amyloid-beta | protective_against | Aβ accumulation | — | 1 |
| Amyloid-beta | regulates | tau pathology | — | 1 |
| Amyloid-beta | interacts_with | tau protein | — | 1 |
Mentioned in (12)
Papers in which this entity is mentioned.
- Epigenetics in Alzheimer's Disease. (2022)
- ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease. (2017)
- Gray matter maturation and cognition in children with different APOE ε genotypes. (2016)
- Three Dimensional Human Neuro-Spheroid Model of Alzheimer's Disease Based on Differentiated Induced Pluripotent Stem Cells. (2016)
- Genetic Restoration of Plasma ApoE Improves Cognition and Partially Restores Synaptic Defects in ApoE-Deficient Mice. (2016)
- Direct Transcriptional Effects of Apolipoprotein E. (2016)
- New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy. (2014)
- ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice. (2013)
- The role of DYRK1A in neurodegenerative diseases. (2011)
- Transgenic mouse models of Alzheimer's disease. (2010)
- Integrative analysis of the melanoma transcriptome. (2010)
- Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration. (2010)
Merged raw entities (4)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| amyloid-beta | drug | 12 | 21 |
| anti-aβ antibodies | drug | 1 | 4 |
| aggregated aβ | drug | — | — |
| aβ proteins | drug | — | — |